Thank you to all of the participants, speakers, and sponsors for making this event a success!
Decades of research in the design of advanced materials and devices using science at the nanoscale are bearing fruit, with sensing, diagnostic and therapeutics solutions ready for commercialization. In the context of the recent announcement of funding of a national network in Nanomedicines by the National Network of Centers of Excellence (NCE) within a thriving ecosystem of superclusters and AI centers, this workshop will explore the state of the art in nanomedicine, the use of technology convergence, and the support needed to bring technologies to the marketplace.
Join us for a Welcome Reception at the Matrix Hotel
the evening of November 4th from 5:30-8:00pm, after Lab2Fab!
|Tuesday, November 5, 2019 |
Matrix Hotel, Edmonton
8:00am – 8:30am
8:45am – 9:55am
Acknowledgement of Traditional Territory
8:55am – 9:00am
Marie D’Iorio – NanoCanada
9:00 a.m. – 9:30 a.m.
Keynote Speaker: Translational Diagnostics with Solid-State Nanopores
Adam Hall – Wake Forest School of Medicine
9:30am – 9:45am
Keynote speaker: The NanoMedicines Innovation Network: Small Molecules, Big Opportunities
Diana Royce – The NanoMedicines Innovation Network
9:45am – 10:15am
Keynote Speaker: Grassroots Innovation for Healthcare
Danina Kapetanovic – Hacking Health
10:15am – 10:45am
Health and Networking Break
10:45am – 11:15am
Keynote Speaker: Convergence of technologies in a thriving ecosystem from a Health City perspective
Reg Joseph – Health City
11:15am – 12:15pm
Panel – What is needed to support the launch and growth of SMES in the convergent tech space?
Evgueni Loukipoudis – Canada’s Digital Supercluster
Karra –Lee Gerrits – Edmonton Global
Samuel Clarke – Precision Nanosystems
Laurence Lejeune – Canadian Network for Scientific Platforms
Moderator – Daylin Breen, Edmonton Economic Development
12:15pm – 1:15pm
1:15pm – 2:15pm
Panel – Translation of health research into applications
Marianna Kulka, NRC- Nanotechnology Research Centre
Wayne Hiebert, NRC-Nanotechnology Research Centre
Jeff Warner – Canadian Light Source
Mel Wong – BioAlberta
Moderator – Lorraine Sheremeta, Alberta Innovates
2:15pm – 3:15pm
Panel – Support in developing novel application spaces
Susanne Riegel – Nanalysis
Jean-Rémi Pouliot – Brilliant Matters
David Chang – Metabolomics Technologies Incorporated
Steven Woodside – STEMCELL Technologies Inc.
Jonanthan Veinot – Applied Quantum Materials Inc.
Moderator – Hooman Hosseinkhannazer, NORCADA
Health and Networking Break
3:45pm – 4:15pm
Keynote: The Path to Quantum Technologies
Barry Sanders – University of Calgary & Quantum Alberta
Panel – How to support advanced manufacturing for emerging technologies
Graham McKinnon – NORCADA
Collin Twanow – Teledyne Micralyne
John Davis – Resolved Instruments
Darryl Short – Karma Machining & Manufacturing
Moderator – Guillermo Ordorica-Garcia, NRC-NANO
5:15pm – 5:20pm
Mr. Daylin Breen leads the business growth activities for the Edmonton Economic Development Corporation (EEDC). In addition to their business intelligence and strategy development roles, Breen and his team help Edmonton businesses grow their sales through EEDC’s export accelerator program and export sales trips.
Prior to joining EEDC, Breen worked independently as a contractor on air cargo business development for Edmonton International Airport and as an associate at an international public relations firm.
Before that, he worked for the Government of Alberta helping entrepreneurs create new products and bring them to market. Earlier in his management career, he worked in the hospitality industry and as a winemaker in Canada’s Okanagan Valley.
Breen holds a Bachelor of Commerce from Royal Roads University and an M.A. in Communications and Technology from the University of Alberta.
Dr. Samuel Clarke is an expert in the development and commercialization of nanoparticles for biomedical applications and has more than 14 years experience in the field. Samuel is currently the Director of R&D at Precision NanoSystems Inc. where he is responsible for nanoparticle reagent development to support applications in gene therapy and precision medicine. Samuel previously worked for STEMCELL Technologies Inc. where he developed and commercialized magnetic nanoparticle technologies for use in research and cell therapy. Samuel studied fluorescent quantum dot nanoparticles for diagnostic applications during his post-doc at the École Normale Supérieure and PhD at McGill University.
Prof. Davis is an Associate Professor in the Department of Physics at the University of Alberta. He obtained his Master’s and Ph.D from Northwestern University in Evanston, Illinois in 2003 and 2008, respectively, studying superfluid 3He. Before that he graduated summa cum laude in physics from Washington University in St. Louis, Missouri. He was awarded the Sloan Research Fellowship in 2013, a Discovery Accelerator in 2016, and has won a number of teaching awards at the University of Alberta. He is currently director of the Quanta CREATE program funded by NSERC and Vice President of Resolved Instruments, makers of advanced digital photodetectors.
Mr. Stéphane Gagné cumulates 24 years of experience in the fields of cosmetics, nutritional supplements, pharmaceutical products and active ingredients. He holds two bachelor’s degrees, one in economics, the other is multidisciplinary, as well as a master’s in business administration.
Mr. Gagné played a significant role in the growth of several Canadian companies abroad through his international network of contacts and business acumen. He held senior positions in biotech, cosmetic and supplement companies, one being Atrium Innovations where he was VP Sales & Marketing from its inception in 1999. Atrium was later acquired by Nestlé in 2017 for 2.3 billion USD.
Mr. Gagné likes to support other entrepreneurs. He volunteered as a Siemens for a number of start-up companies from Cohort 1, 2 and 3 of District Ventures, a business accelerator for health-related companies which is based in Calgary and that was started by Arlene Dickinson, a former dragon at CBD Dragons Den.
Since 2006, Mr. Gagné co-founded 3 companies where he held the role of President & CEO.
Mr. Gagné is now the co-founder, President and CEO of Ovensa Inc., a private company that has developed a nanomedicine delivery platform focusing on fighting tough-to-treat diseases such as cancer and dementia.
Ovensa leverages the cationic charges on its patented biopolymer called TRIOZAN™, to cross the skin, the mucosae or the blood-brain barrier in order to deliver the therapeutic molecule to the targeted tissue or cell. This approach known as precision medicine can be done by adding ligands on the surface of the biopolymer so that the nanoparticles can be more accurate in delivering its payload to where it needs to go and then bringing it inside the cell. Ovensa also uses its technology as a theranostic tool to visualize cancer cells in the brain, kill them and monitor the progression of the treatment. Ovensa now works with large pharmaceutical companies such as Takeda Pharmaceutical to solve challenges using nanotechnology.
Karra-Lee Gerrits joined Edmonton Global in January of 2019, initially as Director of Business Development, assuming the role of VP Investment and Trade in July 2019. From 1999 to 2018, Ms. Gerrits was a Trade Commissioner in Canada’s Foreign Service, promoting Canada’s economic interests on the international stage. Her final role with Global Affairs Canada was as Senior Trade Commissioner and Counsellor for the Innovation, Life and Agri-Food sectors at the Embassy of Canada to Japan. Her previous roles with that organization included assignments abroad in Canada’s Embassies to the Philippines, Mexico, Venezuela and the Netherlands as well as roles in Ottawa. Ms. Gerrits received a Masters’ Degree in Leadership from Royal Roads University in 2018 and a Bachelor of Commerce Degree from the University of Alberta’s School of Business in 1999. She is originally from Grande Prairie, in northern Alberta, but now calls Edmonton home.
Dr. Hall received his training in physics and materials sciences at the University of North Carolina at Chapel Hill, where he conducted research on nanoelectomechanical systems incorporating individual nanomaterials He then spent the next three years as a postdoctoral researcher at Technische Universitat Delft in the Netherlands, where he performed experiments on solid-state nanopores in the lab of Cees Dekker. From 2010-13, he was an Assistant Professor of Nanoscience at the Joint School of Nanoscience and Nanoengineering in Greensboro, NC, where he earned awards for both his research activities and teaching. He joined the faculty of the Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences in August of 2013 as an Assistant Professor in the Wake Forest University School of Medicine. His research is directed towards the implementation of nano- and microtechnologies for translational science. These efforts are focused in two specific areas: molecular detection and diagnostics with the solid-state nanopore platform and novel integrations of 3D cell culture constructs with microfluidic systems for body-on-a-chip applications.
Hooman Hosseinkhannazer (PMP, PEng) is a business executive with experience in advanced technology, oil and gas and the not-for- profit sectors. As the Vice President Business Development at NORCADA in Edmonton, Hooman oversees a broad portfolio of high-tech product solutions with applications in genomics, X-ray optics, vacuum technology, quantum sciences, microscopy and spectroscopy. Hooman’s engineering career started in the field of health robotics before engaging in micro/nano-fabrication and product development via graduate studies at the University of Alberta. Over the last few years at Norcada, Hooman has dedicated his career to the development and commercialization of a number of nanotechnology and MEMS product lines for industrial and research applications, while expanding the market reach to over 45 countries.
Reg Joseph was appointed as the CEO of Health City in February 2018. He has 20 years’ experience spanning the biotechnology, high technology and investment sectors.
Reg has served in a wide variety of roles including: the CEO of a local University of Alberta start-up company, an equity research analyst with Boston-based Leerink Swann & Co. and at US-based Invitrogen Corporation (now Thermo Fisher). Most recently, he served as the Vice President of the Health portfolio at Alberta Innovates. In this role, he led the provincial strategy for health innovation and drove industry and non-profit collaborations with the province.
Reg currently serves as Chair of the Board of BioTalent Canada, sits on BioAlberta’s policy committee and serves as President of the Board for the Seniors Association of Greater Edmonton (SAGE). He has a B.Sc. in Physiology and an MBA in Finance.
Laurence Lejeune was a core facility manager for 10 years at the Lady Davis Institute then at the Centre de Recherche du CHUM. During that time, she trained hundreds of HQP from diverse backgrounds in the fundamentals of cytometry with a focus on quality control and quantitative techniques. She gained industry experience and project management expertise as a sales specialist with Beckman Coulter where she interacted with a broad research community within and outside the cytometry research field. She is currently an independent consultant providing uniquely tailored support for microscopy infrastructure and cytometry training. She has corporate and academic clients across Montreal and Canada. She is a founding member (2005) and past President (2008-2012) of the Canadian Cytometry and Microscopy Association. Under her leadership the group more than doubled in size and expanded to include light microscopy. She is a founding member (2016) and vice president of the CNSP. She has developed extensive experience in project management and tremendous expertise working in complex multi-disciplinary environments.
Evgueni Loukipoudis is the CTO of Canada’s Digital Technology Supercluster. In a career spanning more than 30 years (over 20 of which in Healthcare IT), Evgueni has held increasingly progressive technical and leadership roles in large multinational corporations. Before joining the Supercluster, he was the CTO of McKesson Medical Imaging and then Change Healthcare and prior to this, as a senior leader in Agfa Healthcare he co-led the digital transformation of that corporation. Evgueni has also been part of technology start-ups, participated in open industry-wide initiatives, authored several patents and held academic and research positions. Evgueni holds an MSc in Mathematics and a PhD in Computer Science from the University of Sofia, Bulgaria. His interests are in the areas of medical imaging, digital health, clinical decision support, artificial intelligence and digital twinning.
Graham McKinnon has been an active member in the Alberta nano-MEMS community for over 30 years. Prior to founding Norcada Inc. in 2003, Mr. McKinnon served as Vice President of Research at Micralyne.
Mr. McKinnon has led the development of ground-breaking MEMS products in several areas including microphones, optical switches, DNA sequencing, microfluidics and microscopy. Norcada continues to be a leader in the development of advanced devices for electron beam and x-ray microscopy.
Mr. McKinnon received his M.Sc. degree in Electrical Engineering from the University of Alberta in 1987 for his work on silicon based quantum well devices. He holds eight U.S. patents and has published several technical papers relating to microfabrication, sensors, and MEMS. Mr. McKinnon has supported Canada’s nano-MEMS community by serving on numerous advisory boards and technical committees over his career.
In February 2018, Dr. Guillermo Ordorica-Garcia was appointed Director General of the Nanotechnology Research Centre in Edmonton, Alberta. Previously the Director of Research and Development at NRC’s Energy Mining and Environment Research Centre in Ottawa, Ontario, Dr. Ordorica-Garcia has led research teams and managed capabilities in materials science, energy conversion and storage, and chemical processing. As a career research scientist, he has authored dozens of technical papers and scientific publications in oil sands, solar energy, and carbon capture and storage. During his tenure at the Alberta Research Council (now InnoTech Alberta), he held various positions managing applied research and development activities, notably, as program leader and team leader, in the Clean Energy portfolio. He has ample experience working with both private and public sector organizations, on collaborative partnerships, and in large research initiatives in clean energy and greenhouse gas (GHG) mitigation.
Dr. Ordorica-Garcia is a passionate believer in leadership, collaboration, and capability management. Throughout his career, he has fostered scientific collaborations with Canadian universities, devoting concerted efforts to developing Canada’s next generation of science and technology leaders. He has led multi-disciplinary and diverse research teams across the country and played a significant role in linking Canadian research activities with international efforts like the International Energy Agency’s Greenhouse Gas R&D Program and SolarPACES.
Dr. Ordorica-Garcia holds Ph.D. and MASc degrees in Chemical Engineering from the University of Waterloo in Ontario, specializing in process systems engineering and GHG emissions mitigation. He is a life-long safety advocate and the proud recipient of an NRC Outstanding Achievement Award in Occupational Health and Safety.
He is a car enthusiast, an avid magazine reader, and a fan of wrist watches.
Jean-Rémi Pouliot was born in Quebec City, Canada, and received his B.Sc. in Chemistry from Université Laval in 2011. He was awarded a NSERC Graham-Bell scholarship while doing his Ph.D. under the supervision of Professor Mario Leclerc. His research focused on the development and adaptation of direct (hetero)arylation polymerization with an emphasis on high-performance materials for plastic electronics. Believing in the commercial potential of this technology, he cofounded Brilliant Matters along with Philippe Berrouard in 2016. The idea was to bring sustainable, greener material production methods to the printed electronics market and sub-markets. Due to this innovative business model and high-quality products, he was able to secure and acquire customers all around the world, from Calgary to Tokyo. He successfully led the first round of funding (2018) and currently leading the second one, both to enable successful expansion and secure the company market position. Brilliant Matters won several notable awards such as first place in both ‘Génies en Affaires’ and ‘Grand Prix Jeunesse – Défi OSEntreprendre’.
Susanne Riegel is the Director of Marketing and Product Manager at Nanalysis Corp. (TSXV: NSCI), a start-up technology company turned manufacturer in Calgary, AB, Canada. Nanalysis is a world leader in the development, manufacture and sale of low-field, high-resolution Nuclear Magnetic Resonance (NMR) benchtop spectrometers. As one of the seminal members, her efforts have focused on developing suitable product lines to address key market verticals and promoting them to generate brand awareness in more than 50 countries. Additionally, to proliferate the use of benchtop NMR spectrometers, she has worked with a dedicated application chemistry team and international collaborations to develop and validate NMR methods to aid the commercialization of a ‘benchtop NMR analyzer’ as a disruptive innovation to key industrial market segments for use by non-experts. Susanne serves on the board of directors for NanoCanada and has recently been named guest editor of Magnetic Resonance in Chemistry’s ‘Benchtop NMR Spectrometers: Technology, applications, techniques and future perspectives’ special issue. She completed a MSc in main group catena-phosophorus compounds at Dalhousie University in Halifax and followed that with a PhD in Organometallics at the University of Calgary.
Barry Sanders is Professor and Director of the Institute for Quantum Science and Technology at the University of Calgary, Chair of the Quantum Alberta consortium, and a Fellow of the Optical Society of America, the American Physical Society, the Institute of Physics (UK) and the Royal Society of Canada. He is a leader in quantum computing and a pioneer in practical quantum communication. Sanders has a Thousand Talents Chair at the University of Science and Technology of China and a Vajra Fellowship at the Raman Research Institute in India. He is Editor-in-Chief of the joint German-British gold-open-access New Journal of Physics.
Lori (Lorraine Sheremeta) is a researcher and a lawyer. Called to the British Columbia Bar in 2001, Lori then pursed her Masters of Law focusing on the regulation of emerging technologies. She has held positions in academia at the University of Alberta, the National Research Council (at the then National Institute for Nanotechnology) and the government of Alberta through Alberta Ingenuity Fund, now Alberta Innovates.
In addition to administrative roles at the interface of science, business and government, Lori has a substantive research background focussing on law, policy and ethics relating to nanotechnology, the life sciences, clinical trials and the societal implications of artificial intelligence. Lori has served on Health Canada’s Science Advisory Board and various expert panels. The Council of Canadian Academies expert panel on nanotechnology published “Small is Different: A Science Perspective on the Regulatory Challenges of the Nanoscale” in July 2008. The panel was tasked with evaluating the current state of knowledge of nanomaterials, their health and environmental impacts that could underpin regulatory perspectives on the need for research, risk assessment and surveillance. Much of Lori’s academic work has focused on the commercialization of research, the translation of research findings to society and the role of intellectual property in this process. Lori remains active in areas of clinical ethics, the regulation of professionals, and the law, policy and regulatory challenges surrounding privacy and access that are raised by our increasingly connected and analyzed world.
Originally from Durban, South Africa, Darryl settled with his family in Edmonton over twenty years ago. Since then, he’s enjoyed a career that’s touched on many facets of manufacturing. He has a diploma in Mechanical Engineering Technology from the Northern Alberta Institute of Technology, and is a Journeyman Machinist with Red Seal and Blue Seal certifications. He’s done manual and CNC machining with a wide variety of equipment, and launched lean thinking within a large international energy equipment manufacturer.
In 2011, he started Catchball Consulting, specializing in lean manufacturing and productivity improvement. Later that year, he bought Karma Machining and Manufacturing, a full-service contract manufacturer helping innovators realize their dreams, from prototype to production. Since then, he and his partner have since grown the business three-fold, with no end in sight.
Karma has been diversifying into new markets and recently launched Karma Medical Products to help support the Rehab Medicine community. KAR/MED is currently developing upper extremity rehab products that strengthen and evaluate therapy. Karma is also working on implantable devices and the regulations supporting this.
From Idea to Concept, Prototype to Production Karma continues to help entrepreneurs and companies.
Darryl and his wife enjoy all that the West has to offer, including camping, photography, motorcycling, and marine aquaria.
Dr. Jeff Warner manages the Industrial Science group at the Canadian Light Source (CLS), an operating third generation synchrotron located in Saskatoon, Saskatchewan, Canada. The Canadian Light Source is the only synchrotron in Canada and one of a few dozen in the world.
Dr. Warner has a B.Sc. and M.Sc. in Chemistry from Carleton University in Ottawa, ON and obtained his Ph.D. from the University of California, Davis. His interest and experience in synchrotron science was cultivated from post-doctoral work at Stanford University and the Lawrence Berkeley National Laboratory in Berkeley, California.
The synchrotron operates in many scientific research areas with over twenty-five percent of publications being in clinical and biomedical research. Published papers in these fields have citation factors well above the Canadian average and appear in journals of high impact factor. The Canadian Light Source has assisted researchers in making significant advances in cystic fibrosis, osteoporosis, malaria, cancer, Alzheimer’s research and is involved in the production of isotopes for medical use. In addition, the pharmaceutical industry is an active user of our macromolecular crystallography beamlines to aid in the development of new drugs.
Dr. Steven Woodside has a BEng in Chemical Engineering from McGill University and a PhD in Chemical Engineering from UBC. He joined STEMCELL Technologies in 1999, and over the past two decades has been instrumental in the development of new cell separation technologies and assay automation tools. Dr. Woodside is now responsible for product development encompassing particle synthesis, antibody, recombinant molecule generation, and bioengineering within STEMCELL’s Research & Development Department.
DAY 1: Lab2Fab will be held at NRC Nanotechnology Research Centre
DAY 2: Advanced Materials for Nanotechnologies and Health will be held at the Matrix Hotel
DAY 3: Microfabrication Process Engineering Using XperiDesk will be held at the University of Alberta.
– Click “more options” at the top left of the map to modify locations and transportation type.
– Details of travel from airport to hotel are below map.
Edmonton Airport (YEG) to Matrix Hotel
There is a shuttle that departs every 60 minutes on the half hour for downtown locations (the Matrix Hotel). Upon arrival, proceed to the skyshuttle check-in desk on the Arrivals level near door 7.
For details, including fares, visit: https://flyeia.com/parking-transportation/skyshuttle/